523 (Cefpodoxime 200 mg)
Pill imprint 523 has been identified as Cefpodoxime proxetil 200 mg.
Cefpodoxime is used in the treatment of upper respiratory tract infection; sinusitis; gonococcal infection, disseminated; pneumonia; skin infection (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefpodoxime 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 523 (Cefpodoxime 200 mg)
Cefpodoxime proxetil
- Imprint:
-
523
- Strength:
- 200 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Northstar Rx LLC
- National Drug Code (NDC):
- 16714-0212
- Inactive Ingredients:
- carboxymethylcellulose calcium
croscarmellose sodium
sodium lauryl sulfate
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
hypromellose 2910 (6 mPa.s)
titanium dioxide
propylene glycol
FD&C Yellow No. 6
FD&C Red No. 40
More resources
Cefpodoxime proxetil is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
